Literature DB >> 21792712

Decreasing morbidity and mortality in 100 consecutive minimally invasive esophagectomies.

Kfir Ben-David1, George A Sarosi, Juan C Cendan, Drew Howard, Georgios Rossidis, Steven N Hochwald.   

Abstract

INTRODUCTION: Esophagectomy is a complex invasive procedure that requires exploration of multiple body cavities for removal and subsequent restoration of gastrointestinal continuity. In many institutions, esophagectomy morbidity and mortality rates remain high despite improvement of intensive care treatment. We reviewed our minimally invasive esophagectomy (MIE) experience of a consecutive series of 100 patients to analyze trends in morbidity and mortality as we transitioned from open to MIE.
METHODS: A total of 105 consecutive patients who underwent operative exploration for esophagectomy from August 2007 to January 2011 were reviewed. The preoperative evaluation, operative technique, and postoperative care of these cases were evaluated and analyzed for 100 patients who have had a MIE and compared with 32 open esophagectomies 2 years prior.
RESULTS: During the time frame of the study, 105 patients underwent an exploration for attempted esophagectomy. Resection was completed in 100 patients and was done for malignant disease in 95 patients and benign disease in 5 patients. There was one in hospital mortality due to a pulmonary embolism. There was no significant difference in postoperative complications consisting of transient left recurrent nerve injury (7 vs. 12.5%) or pneumonia (9 vs. 15.6%) in those who underwent MIE compared with open resection. However, wound infections were significantly less in patients who underwent MIE compared with open esophagectomy (1 vs. 12.5%, respectively, p = 0.01). Anastomotic leak (4 vs. 12.5%, p = 0.05) also was lower in those who underwent MIE. Median length of stay (LOS) was significantly less in patients who underwent MIE compared with open esophagectomy (7.5 vs. 14 days, p < 0.05). Finally, there was a trend toward improvement in median LOS in the 30 patients who underwent MIE during the most recent time period compared with the initial 17 patients who underwent MIE (7.5 vs. 10 days, p = 0.05)
CONCLUSIONS: Our results support the continued safe use of esophagectomy for selected esophageal diseases, including malignancy. Morbidity, especially wound infection, anastomotic leak, and length of stay is decreasing with the incorporation of minimally invasive techniques.

Entities:  

Mesh:

Year:  2011        PMID: 21792712     DOI: 10.1007/s00464-011-1846-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  36 in total

1.  Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.

Authors:  Joerg R Siewert; Florian Lordick; Katja Ott; Hubert J Stein; Wolfgang A Weber; Karen Becker; Christian Peschel; Ulrich Fink; Markus Schwaiger
Journal:  Ann Surg       Date:  2007-10       Impact factor: 12.969

Review 2.  Minimally invasive oesophagectomy: current status and future direction.

Authors:  Nick Butler; Stuart Collins; Breda Memon; Muhammed Ashraf Memon
Journal:  Surg Endosc       Date:  2011-02-07       Impact factor: 4.584

3.  Minimally invasive versus open esophagectomy: meta-analysis of outcomes.

Authors:  George Sgourakis; Ines Gockel; Arnold Radtke; Thomas J Musholt; Stephan Timm; Andreas Rink; Achilleas Tsiamis; Constantine Karaliotas; Hauke Lang
Journal:  Dig Dis Sci       Date:  2010-02-26       Impact factor: 3.199

4.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

Review 5.  Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference?

Authors:  R Rindani; C J Martin; M R Cox
Journal:  Aust N Z J Surg       Date:  1999-03

Review 6.  Autoimmune esophagitis: IgG4-related tumors of the esophagus.

Authors:  James Lopes; Steven N Hochwald; Nicholas Lancia; Lisa R Dixon; Kfir Ben-David
Journal:  J Gastrointest Surg       Date:  2010-03-02       Impact factor: 3.452

7.  Minimally invasive esophagectomy is safe and effective following neoadjuvant chemoradiation therapy.

Authors:  Kfir Ben-David; George Rossidis; Robert A Zlotecki; Stephen R Grobmyer; Juan C Cendan; George A Sarosi; Steven N Hochwald
Journal:  Ann Surg Oncol       Date:  2011-04-09       Impact factor: 5.344

Review 8.  Reducing hospital morbidity and mortality following esophagectomy.

Authors:  B Zane Atkins; Ashish S Shah; Kelley A Hutcheson; Jennifer H Mangum; Theodore N Pappas; David H Harpole; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

9.  Minimally invasive esophagectomy: outcomes in 222 patients.

Authors:  James D Luketich; Miguel Alvelo-Rivera; Percival O Buenaventura; Neil A Christie; James S McCaughan; Virginia R Litle; Philip R Schauer; John M Close; Hiran C Fernando
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

10.  Centralization of esophageal cancer surgery: does it improve clinical outcome?

Authors:  M W J M Wouters; H E Karim-Kos; S le Cessie; B P L Wijnhoven; L P S Stassen; W H Steup; H W Tilanus; R A E M Tollenaar
Journal:  Ann Surg Oncol       Date:  2009-04-16       Impact factor: 5.344

View more
  34 in total

1.  Nationwide analysis of short-term surgical outcomes of minimally invasive esophagectomy for malignancy.

Authors:  Pragatheeshwar Thirunavukarasu; Emmanuel Gabriel; Kristopher Attwood; Moshim Kukar; Steven N Hochwald; Steven J Nurkin
Journal:  Int J Surg       Date:  2015-11-18       Impact factor: 6.071

2.  Comparison of pyloric intervention strategies at the time of esophagectomy: is more better?

Authors:  Mara B Antonoff; Varun Puri; Bryan F Meyers; Kevin Baumgartner; Jennifer M Bell; Stephen Broderick; A Sasha Krupnick; Daniel Kreisel; G Alexander Patterson; Traves D Crabtree
Journal:  Ann Thorac Surg       Date:  2014-04-21       Impact factor: 4.330

3.  A non-randomized retrospective observational study on the subcutaneous esophageal reconstruction after esophagectomy: is it feasible in high-risk patients?

Authors:  Jae Ho Chung; Sung Ho Lee; Eunjue Yi; Jae Seung Jung; Jung Wook Han; Tae Sik Kim; Ho Sung Son; Kwang Taik Kim
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

4.  Contemporary issues in endoscopic resection for esophageal squamous cell cancer.

Authors:  Emmanuel Gabriel; Steven N Hochwald
Journal:  Ann Transl Med       Date:  2017-01

Review 5.  Minimally invasive esophagectomy for esophageal cancer: an updated review.

Authors:  Masayuki Watanabe; Yoshifumi Baba; Yohei Nagai; Hideo Baba
Journal:  Surg Today       Date:  2012-08-28       Impact factor: 2.549

Review 6.  Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes.

Authors:  Danica N Giugliano; Adam C Berger; Ernest L Rosato; Francesco Palazzo
Journal:  Langenbecks Arch Surg       Date:  2016-07-11       Impact factor: 3.445

7.  Minimally Invasive Ivor-Lewis Esophagectomy (MIILE): A Single-Center Experience.

Authors:  Jun Wang; Mei-Qing Xu; Ming-Ran Xie; Xin-Yu Mei
Journal:  Indian J Surg       Date:  2016-07-12       Impact factor: 0.656

8.  Implementation of minimally invasive esophagectomy in a tertiary referral center for esophageal cancer.

Authors:  Magnus Nilsson; Satoshi Kamiya; Mats Lindblad; Ioannis Rouvelas
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

9.  Pre-therapy laparoscopic feeding jejunostomy is safe and effective in patients undergoing minimally invasive esophagectomy for cancer.

Authors:  Kfir Ben-David; Tad Kim; Angel M Caban; Georgios Rossidis; Sara S Rodriguez; Steven N Hochwald
Journal:  J Gastrointest Surg       Date:  2013-05-25       Impact factor: 3.452

10.  Laparoscopic gastric tube formation with pyloromyotomy for reconstruction in patients with esophageal cancer.

Authors:  Jin Won Lee; Sook Whan Sung; Jae Kil Park; Cho Hyun Park; Kyo Young Song
Journal:  Ann Surg Treat Res       Date:  2015-08-24       Impact factor: 1.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.